Back to Search Start Over

[Cost Effectiveness of Treatments of Psoriasis with a PASI 75 and one Period of 12 Weeks].

Authors :
Alfageme Roldán F
Bermejo Hernando A
Calvo González JL
Marqués Sánchez P
Source :
Revista espanola de salud publica [Rev Esp Salud Publica] 2016 Apr 13; Vol. 90, pp. E15. Date of Electronic Publication: 2016 Apr 13.
Publication Year :
2016

Abstract

Objective: The objective was to evaluate the efficiency (relation between the cost and the results in health) of the treatments in psoriasis, seeking a higher quality of economic evaluations, consistency and transparency in these studies.<br />Methods: We developed a model of economic evaluation in psoriasis collecting all the many direct and indirect costs of each treatment. The effectiveness indicator used was Psoriasis Area Severity Index [PASI 75] which is generally acceptable in studies of psoriasis. The effectiveness indicator was a PASI 75.Subsequently we calculated the Incremental Cost-Effectiveness Ratio (ICER) for the period of 12 weeks and PASI 75, ordering treatments by level of effectiveness at the expense of treatment costs.<br />Results: The most cost effective treatment was methotrexate (ICER -7.5) followed by acitretin (ICER 29.5). The least cost has proved effective PUVA (ICER 4,651), followed by UVB narrow band (2,886.1).<br />Conclusions: when taking into account both direct and indirect costs together with efficiency, methotrexate is the most cost effective treatment.

Details

Language :
Spanish; Castilian
ISSN :
2173-9110
Volume :
90
Database :
MEDLINE
Journal :
Revista espanola de salud publica
Publication Type :
Academic Journal
Accession number :
27073006